{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:13:32Z","timestamp":1776662012886,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/aps.2015.153","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T10:00:38Z","timestamp":1456740038000},"page":"519-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression"],"prefix":"10.1038","volume":"37","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Fu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-gang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-liu","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"BFaps2015153_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4419-0284-9_12","volume":"152","author":"N Jaffe","year":"2009","unstructured":"Jaffe N . Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res 2009; 152: 239\u201362.","journal-title":"Cancer Treat Res"},{"key":"BFaps2015153_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.trsl.2014.06.005","volume":"164","author":"Z Milosevic","year":"2014","unstructured":"Milosevic Z, Pesic M, Stankovic T, Dinic J, Milovanovic Z, Stojsic J, et al. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma. Transl Res 2014; 164: 411\u201323.","journal-title":"Transl Res"},{"key":"BFaps2015153_CR3","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/bcr3640","volume":"16","author":"H Zhang","year":"2014","unstructured":"Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Res 2014; 16: R36.","journal-title":"Breast Cancer Res"},{"key":"BFaps2015153_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2014.01.014","volume":"346","author":"WK Utomo","year":"2014","unstructured":"Utomo WK, Narayanan V, Biermann K, van Eijck CH, Bruno MJ . mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. Cancer Lett 2014; 346: 309\u201317.","journal-title":"Cancer Lett"},{"key":"BFaps2015153_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/0008-5472.CAN-12-3241","volume":"74","author":"H Okazaki","year":"2014","unstructured":"Okazaki H, Matsunaga N, Fujioka T, Okazaki F, Akagawa Y, Tsurudome Y, et al. Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma. Cancer Res 2014; 74: 543\u201351.","journal-title":"Cancer Res"},{"key":"BFaps2015153_CR6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.V80.6.1528.1528","volume":"80","author":"RJ Arceci","year":"1992","unstructured":"Arceci RJ, Stieglitz K, Bierer BE . Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 1992; 80: 1528\u201336.","journal-title":"Blood"},{"key":"BFaps2015153_CR7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.4161\/auto.26447","volume":"9","author":"Y Wang","year":"2013","unstructured":"Wang Y, Hu Z, Liu Z, Chen R, Peng H, Guo J, et al. MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1. Autophagy 2013; 9: 2069\u201386.","journal-title":"Autophagy"},{"key":"BFaps2015153_CR8","first-page":"588","volume":"20","author":"S Zhao","year":"2015","unstructured":"Zhao S, Lu N, Chai Y, Yu X . Rapamycin inhibits tumor growth of human osteosarcomas. J BUON 2015; 20: 588\u201394.","journal-title":"J BUON"},{"key":"BFaps2015153_CR9","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1038\/cddis.2011.139","volume":"3","author":"GM Ajabnoor","year":"2012","unstructured":"Ajabnoor GM, Crook T, Coley HM . Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells. Cell Death Dis 2012; 3: e260.","journal-title":"Cell Death Dis"},{"key":"BFaps2015153_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.mehy.2011.07.004","volume":"77","author":"MF McCarty","year":"2011","unstructured":"McCarty MF . mTORC1 activity as a determinant of cancer risk \u2014 rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets. Med Hypotheses 2011; 77: 642\u20138.","journal-title":"Med Hypotheses"},{"key":"BFaps2015153_CR11","doi-asserted-by":"publisher","first-page":"e11013","DOI":"10.1371\/journal.pone.0011013","volume":"5","author":"MC Paoloni","year":"2010","unstructured":"Paoloni MC, Mazcko C, Fox E, Fan T, Lana S, Kisseberth W, et al. Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs. PLoS One 2010; 5: e11013.","journal-title":"PLoS One"},{"key":"BFaps2015153_CR12","doi-asserted-by":"publisher","first-page":"e0132767","DOI":"10.1371\/journal.pone.0132767","volume":"10","author":"F Navarro","year":"2015","unstructured":"Navarro F, Lieberman J . miR-34 and p53: new insights into a complex functional relationship. PLoS One 2015; 10: e0132767.","journal-title":"PLoS One"},{"key":"BFaps2015153_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2015.04.016","volume":"85","author":"W Li","year":"2015","unstructured":"Li W, Han W, Ma Y, Cui L, Tian Y, Zhou Z, et al. P53-dependent miRNAs mediate nitric oxide-induced apoptosis in colonic carcinogenesis. Free Radic Biol Med 2015; 85: 105\u201313.","journal-title":"Free Radic Biol Med"},{"key":"BFaps2015153_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jmcb\/mju003","volume":"6","author":"M Rokavec","year":"2014","unstructured":"Rokavec M, Li H, Jiang L, Hermeking H . The p53\/miR-34 axis in development and disease. J Mol Cell Biol 2014; 6: 214\u201330.","journal-title":"J Mol Cell Biol"},{"key":"BFaps2015153_CR15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18632\/oncotarget.1202","volume":"4","author":"H Siemens","year":"2013","unstructured":"Siemens H, Jackstadt R, Kaller M, Hermeking H . Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 2013; 4: 1399\u2013415.","journal-title":"Oncotarget"},{"key":"BFaps2015153_CR16","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.2174\/138945012804545515","volume":"13","author":"B Bao","year":"2012","unstructured":"Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, et al. Targeting CSC-related miRNAs for cancer therapy by natural agents. Curr Drug Targets 2012; 13: 1858\u201368.","journal-title":"Curr Drug Targets"},{"key":"BFaps2015153_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1755-8794-4-79","volume":"4","author":"CH Kim","year":"2011","unstructured":"Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, et al. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics 2011; 4: 79.","journal-title":"BMC Med Genomics"},{"key":"BFaps2015153_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2014.10.032","volume":"554","author":"L Wang","year":"2014","unstructured":"Wang L, Yu J, Xu J, Zheng C, Li X, Du J . The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues. Gene 2014; 554: 1\u20138.","journal-title":"Gene"},{"key":"BFaps2015153_CR19","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/mt.2013.148","volume":"21","author":"J Zhao","year":"2013","unstructured":"Zhao J, Lammers P, Torrance CJ, Bader AG . TP53-independent function of miR-34a via HDAC1 and p21 (CIP1\/WAF1). Mol Ther 2013; 21: 1678\u201386.","journal-title":"Mol Ther"},{"key":"BFaps2015153_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3892\/ijo.2013.1767","volume":"42","author":"LG Wang","year":"2013","unstructured":"Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ . MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int J Oncol 2013; 42: 957\u201362.","journal-title":"Int J Oncol"},{"key":"BFaps2015153_CR21","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.4161\/cc.9.14.12182","volume":"9","author":"IG Cannell","year":"2010","unstructured":"Cannell IG, Bushell M . Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? Cell Cycle 2010; 9: 2726\u201330.","journal-title":"Cell Cycle"},{"key":"BFaps2015153_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3892\/or.2013.2351","volume":"29","author":"N Tanaka","year":"2013","unstructured":"Tanaka N, Toyooka S, Soh J, Tsukuda K, Shien K, Furukawa M, et al. Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep 2013; 29: 2169\u201374.","journal-title":"Oncol Rep"},{"key":"BFaps2015153_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","volume":"47","author":"ME Anderson","year":"2016","unstructured":"Anderson ME . Update on survival in osteosarcoma. Orthop Clin North Am 2016; 47: 283\u201392.","journal-title":"Orthop Clin North Am"},{"key":"BFaps2015153_CR24","doi-asserted-by":"publisher","first-page":"ra121","DOI":"10.1126\/scisignal.aaa1877","volume":"7","author":"CA Martz","year":"2014","unstructured":"Martz CA, Ottina KA, Singleton KR, Jasper JS, Wardell SE, Peraza-Penton A, et al. Systematic identification of signaling pathways with potential to confer anticancer drug resistance. Sci Signal 2014; 7: ra121.","journal-title":"Sci Signal"},{"key":"BFaps2015153_CR25","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.leukres.2013.09.002","volume":"37","author":"JL Liesveld","year":"2013","unstructured":"Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, et al. A phase I study of decitabine and rapamycin in relapsed\/refractory AML. Leuk Res 2013; 37: 1622\u20137.","journal-title":"Leuk Res"},{"key":"BFaps2015153_CR26","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1158\/1078-0432.CCR-12-1158","volume":"18","author":"J Moroney","year":"2012","unstructured":"Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, et al. Phase I study of the antiangiogenic antibody bevacizumab and the mTOR\/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res 2012; 18: 5796\u2013805.","journal-title":"Clin Cancer Res"},{"key":"BFaps2015153_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/10428190903046722","volume":"50","author":"IV Pop","year":"2009","unstructured":"Pop IV, Pop LM, Ghetie MA, Vitetta ES . Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines. Leuk Lymphoma 2009; 50: 1155\u201362.","journal-title":"Leuk Lymphoma"},{"key":"BFaps2015153_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-03-0043","volume":"10","author":"WC Noh","year":"2004","unstructured":"Noh WC, Mondesire WH, Peng J, Jian W, Zhang H, Dong J, et al. Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res 2004; 10: 1013\u201323.","journal-title":"Clin Cancer Res"},{"key":"BFaps2015153_CR29","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1016\/j.bmcl.2013.08.018","volume":"23","author":"MJ Ramaiah","year":"2013","unstructured":"Ramaiah MJ, Pushpavalli SN, Lavanya A, Bhadra K, Haritha V, Patel N, et al. Novel anthranilamide-pyrazolo [1,5-a] pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorg Med Chem Lett 2013; 23: 5699\u2013706.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFaps2015153_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4161\/cc.11.2.18900","volume":"11","author":"T Brabletz","year":"2012","unstructured":"Brabletz T . MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity\/EMT governed by p53. Cell Cycle 2012; 11: 215\u20136.","journal-title":"Cell Cycle"},{"key":"BFaps2015153_CR31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s13277-013-1207-z","volume":"35","author":"K Jin","year":"2014","unstructured":"Jin K, Xiang Y, Tang J, Wu G, Li J, Xiao H, et al. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. Tumour Biol 2014; 35: 1503\u201310.","journal-title":"Tumour Biol"},{"key":"BFaps2015153_CR32","doi-asserted-by":"publisher","first-page":"11836","DOI":"10.1074\/jbc.M610106200","volume":"282","author":"H Ishida","year":"2007","unstructured":"Ishida H, Li K, Yi M, Lemon SM . p21-activated kinase 1 is activated through the mammalian target of rapamycin\/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells. J Biol Chem 2007; 282: 11836\u201348.","journal-title":"J Biol Chem"},{"key":"BFaps2015153_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-12114-7_5","volume":"846","author":"A Hammer","year":"2015","unstructured":"Hammer A, Diakonova M . Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion. Adv Exp Med Biol 2015; 846: 97\u2013137.","journal-title":"Adv Exp Med Biol"},{"key":"BFaps2015153_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s13277-012-0327-1","volume":"33","author":"H Qing","year":"2012","unstructured":"Qing H, Gong W, Che Y, Wang X, Peng L, Liang Y, et al. PAK1-dependent MAPK pathway activation is required for colorectal cancer cellproliferation. Tumour Biol 2012; 33: 985\u201394.","journal-title":"Tumour Biol"},{"key":"BFaps2015153_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.yexmp.2014.08.002","volume":"97","author":"H Maroof","year":"2014","unstructured":"Maroof H, Salajegheh A, Smith RA, Lam AK . Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. Exp Mol Pathol 2014; 97: 298\u2013304.","journal-title":"Exp Mol Pathol"},{"key":"BFaps2015153_CR36","first-page":"1603","volume":"32","author":"J Bal\u00e7a-Silva","year":"2012","unstructured":"Bal\u00e7a-Silva J, Sousa Neves S, Gon\u00e7alves AC, Abrantes AM, Casalta-Lopes J, Botelho MF, et al. Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines. Anticancer Res 2012; 32: 1603\u20139.","journal-title":"Anticancer Res"},{"key":"BFaps2015153_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2015.10.023","volume":"370","author":"Z Ye","year":"2016","unstructured":"Ye Z, Fang J, Dai S, Wang Y, Fu Z, Feng W, et al. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background. Cancer Lett 2016; 370: 216\u201321.","journal-title":"Cancer Lett"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2015153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2015153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2015153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:32:48Z","timestamp":1684413168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2015153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFaps2015153"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.153","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"assertion":[{"value":"25 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}